Position history for RTW INVESTMENTS, LP's holdings in ULTRAGENYX PHARMACEUTICAL IN
RTW INVESTMENTS, LP holds 3.6M shares of RARE (ULTRAGENYX PHARMACEUTICAL IN), worth $76.4M as of 2026-Q1. The position was increased (+21.6% shares). RARE represents 0.8% of RTW INVESTMENTS, LP's portfolio.
Current Value
$76.4M
Current Shares
3.6M
Total Value Change
-$57.5M
Total Shares Change
+388,868
Other major holders of RARE: UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC
Increased |
| 3.6M |
+21.6% |
| $76.4M |
| 0.8% |
| $22.07 |
50 |
| 2025-Q4 | Decreased | 3M | -7.9% | $69M | 0.7% | $22.78 | 0 |
| 2025-Q3 | Increased | 3.3M | +90.8% | $98M | 1.2% | $30.36 | 74 |
| 2025-Q2 | Unchanged | 1.7M | 0.0% | $62.1M | 0.9% | $36.52 | 0 |
| 2025-Q1 | Decreased | 1.7M | -13.2% | $61.8M | 0.9% | $37.82 | 0 |
| 2024-Q4 | Unchanged | 2M | 0.0% | $82.8M | 1.3% | $42.27 | 0 |
| 2024-Q3 | Decreased | 2M | -39.6% | $109.3M | 1.6% | $54.43 | 0 |
| 2024-Q2 | Decreased | 3.3M | -54.0% | $134M | 2.1% | $41.10 | 0 |